Neurology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust and The University of Sheffield, Glossop Road, Sheffield S10 2JF, United Kingdom.
Neurology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust and The University of Sheffield, Glossop Road, Sheffield S10 2JF, United Kingdom.
Mult Scler Relat Disord. 2022 Aug;64:103954. doi: 10.1016/j.msard.2022.103954. Epub 2022 Jun 7.
Fatigue is a widely experienced, incapacitating symptom of MS. It hinders daily functioning and has deleterious effects on quality of life. The UK MS Register is an online registry of over 20,000 participants with MS. The aim of this study was to estimate the prevalence, predictors, and impact of fatigue on people with MS using data from the UKMS register.
All participants who completed the Fatigue Severity Scale (FSS), WebEDSS, Hospital Anxiety and Depression Scale (HADS) within 28 days of each other were selected from the UK MS Register. Data on age, gender, duration and type of MS, use of disease modifying drugs and comorbidities were obtained from the UKMS register. We categorised people with FSS score of 5 or more as with fatigue and those with scores of 4 or less as without fatigue. Descriptive statistics and logistical and multiple regressions were used to explore predictors of fatigue and the effect of fatigue on mobility (MS Walking Scale), physical and psychological aspects of life (MS Impact Scale) and quality of life (European Quality of Life 5D-3 L).
Amongst the 20,946 participants of the UK MS registry, 4620 completed FSS. Out of these, 775 (mean age= 54.71 years, SD= 10.90; mean duration of MS diagnosis =13.21 years, SD=9.75) had completed the FSS, Web EDSS and Hospital Anxiety and Depression Scale within 28 days of each other. 427 (55.1%) of pwMS had a FSS score >5 consistent with clinical fatigue. Logistic regression analysis showed that depression (p=<0.001), duration of MS (p = 0.017), secondary progressive MS (p = 0.001) and EDSS (p=<0.001) predicted fatigue. FSS scores had a significant negative impact on both psychological (p > 0.001) and physical (p > 0.001) domains of the MS Impact scale, MS walking scale (p = 0.003) and EQoL (p = 0.005).
Fatigue was a common symptom amongst people with MS. Depression, longer duration of MS, secondary progressive MS, and high EDSS predicted fatigue. Fatigue had an adverse effect on physical activities, mobility, psychological wellbeing, and quality of life of people with MS.
疲劳是多发性硬化症(MS)患者普遍经历的一种使人虚弱的症状。它会妨碍日常活动,并对生活质量产生有害影响。英国 MS 注册中心是一个拥有 20,000 多名 MS 参与者的在线注册中心。本研究的目的是使用来自 UKMS 注册中心的数据来估计 MS 患者疲劳的患病率、预测因素和对其的影响。
从英国 MS 登记册中选择了在 28 天内完成疲劳严重程度量表(FSS)、WebEDSS、医院焦虑和抑郁量表(HADS)的所有参与者。从 UKMS 登记册中获得了年龄、性别、MS 持续时间和类型、使用疾病修正药物和合并症的数据。我们将 FSS 得分为 5 或更高的人归类为有疲劳,将得分 4 或更低的人归类为无疲劳。使用描述性统计、逻辑回归和多元回归来探讨疲劳的预测因素以及疲劳对移动能力(MS 步行量表)、身体和心理生活方面(MS 影响量表)以及生活质量(欧洲生活质量 5D-3L)的影响。
在英国 MS 登记册的 20946 名参与者中,有 4620 人完成了 FSS。在这些人中,有 775 人(平均年龄=54.71 岁,标准差=10.90;平均 MS 诊断持续时间=13.21 年,标准差=9.75)在 28 天内完成了 FSS、WebEDSS 和医院焦虑和抑郁量表。427 名(55.1%)pwMS 的 FSS 评分>5,与临床疲劳一致。逻辑回归分析表明,抑郁(p<0.001)、MS 持续时间(p=0.017)、继发进展型 MS(p=0.001)和 EDSS(p<0.001)预测疲劳。FSS 评分对 MS 影响量表的心理(p>0.001)和身体(p>0.001)域、MS 步行量表(p=0.003)和 EQoL(p=0.005)均有显著的负面影响。
疲劳是 MS 患者的常见症状。抑郁、MS 持续时间较长、继发进展型 MS 和较高的 EDSS 预测疲劳。疲劳对 MS 患者的身体活动、移动能力、心理幸福感和生活质量有不良影响。